Overview

Psilocybin for Hospitalized Patients with Treatment-resistant Depression

Status:
RECRUITING
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and feasibility of performing psilocybin-assisted psychotherapy in patients hospitalized for treatment-resistant depression.
Phase:
PHASE2
Details
Lead Sponsor:
University Hospital, Ghent
Collaborator:
Filament Health Corp.
Treatments:
Psilocybin